News Conference News HFSA 2024 FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone? Michael O'Riordan October 02, 2024
News Conference News ESC 2024 More Data Diminish Support for Cath Lab Fasting Rules: SCOFF L.A. McKeown September 10, 2024
News Conference News ESC 2024 Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery Todd Neale August 30, 2024
News Daily News ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions Caitlin E. Cox August 16, 2024
News Daily News Tirzepatide Provides Sustained BP Reduction in Overweight Adults Todd Neale August 15, 2024
News Daily News Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF Michael O'Riordan July 26, 2024
News Daily News Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF Todd Neale July 19, 2024
Presentation NY Valves 2024 An Unusual Cause for Hypotension After Complex Transcatheter Edge to Edge Repair Presenter: Yashasvi Chugh June 06, 2024
News Conference News ESC Heart Failure 2024 Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients Michael O'Riordan May 13, 2024
News Daily News Balancing Hypertension and Fall Risk: A Delicate Dance in Elderly Patients L.A. McKeown April 22, 2024
News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP L.A. McKeown April 16, 2024
News Conference News ACC 2024 KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives Shelley Wood April 11, 2024
News Conference News ACC 2024 Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock Caitlin E. Cox April 07, 2024
News Daily News Salt Substitute Slashes New Hypertension Diagnoses: DECIDE-Salt L.A. McKeown February 14, 2024
News Daily News GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks Todd Neale January 21, 2024
News Daily News Small Arrhythmia Risk Seen When Medical Cannabis Used for Pain Todd Neale January 18, 2024
News Conference News AHA 2023 Large Study Affirms Safety of Pulsed-Field Ablation, Reveals Some Rare Complications Todd Neale November 13, 2023
News Conference News AHA 2023 RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1 Caitlin E. Cox November 11, 2023
News Conference News HFSA 2023 STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization L.A. McKeown October 18, 2023
News Daily News Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle Todd Neale September 12, 2023